Pharmafile Logo
Pharmafocus logo
Advanced Search

Mylan

Showing 15 posts of 123 posts found.

teva_copy

Teva hit by patent blow upon top-selling MS drug

January 31, 2017
Manufacturing and Production Mylan, Teva, generic, multiple sclerosis

Teva endured a rough ride in 2016, seeing its market value sink progressively over the course of the year. It …

News
kaleo

Rival to EpiPen to be made available to many for free

January 23, 2017
Manufacturing and Production, Sales and Marketing Kaleo, Mylan, epipen, rival

Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …

News
1280px-epi-pen_1

Drugstore chain CVS offers EpiPen generic for 600% cheaper

January 12, 2017
Medical Communications, Sales and Marketing CVS, Mylan, epipen

The Mylan EpiPen scandal was one of last year’s most closely-followed stories, as the industry reacted with scorn to CEO …

News
biocon_office

Mylan and Biocon apply to FDA for biosimilar approval

January 12, 2017
Sales and Marketing Biocon, FDA, Mylan, biosimilar, trastuzumab

Mylan, the US-based generics specialist, and Biocon, an Indian biopharmaceutical company, have applied for a biologics license application (BLA) for …

News

Mylan ends 2016 with spate of generics

January 3, 2017
Manufacturing and Production, Sales and Marketing Mylan, generics, launch

Mylan ended a difficult year for itself by releasing a rash of generics into the market, ending the year strongly …

News
1280px-epi-pen_1

Mylan launches $300 generic EpiPen to calm pricing controversy

December 16, 2016
Sales and Marketing Mylan, epipen

Mylan has launched a generic alternative to its flagship EpiPen auto-injector, a move to placate the outbreak of industry indignity …

News
dominos

Six generics companies hit by 20-state-strong lawsuit

December 16, 2016
Medical Communications Heritage, Mylan, Teva

Following hot on the heels of yesterday’s news that a former CEO and president of Heritage Pharmaceuticals had been charged …

News

Mylan to restructure and slash around 10% of workforce

December 8, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, epipen, job losses

Mylan has submitted a regulatory filing to the Securities and Exchange Commission to announce that it would be potentially cutting …

News

Mylan ducks call to testify in front of Senate

November 22, 2016
Manufacturing and Production, Medical Communications Department of Justice, Mylan, epipen

Mylan has avoided the call to testify in front of the Senate judiciary committee. The hearing will be convened under …

News
19199400883_6db786ce0d_b

Price hiking: US pharma’s elephant in the room

October 26, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Martin Shkreli, Mylan, Sanofi, Turing Pharmaceuticals, price hikes

Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending debate on the power of drug companies to charge …

Feature
1280px-epi-pen_1

Mylan agrees $465m settlement over EpiPen misclassification

October 10, 2016
Business Services, Medical Communications, Sales and Marketing Heather Bresch, Mylan, Price hike, epipen

In the latest scandal in the EpiPen price hike saga, the US Department of Justice has made claims that the …

News

“Incorrect classification” of EpiPen leads to $1 billion bill for US government

October 6, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, Heather Bresch, Misclassification, Mylan, Price hike, classification, epipen, price, scandal

Mylan’s EpiPen woes show no sign of abating after CMS (Centers for Medicare and Medicaid Services) released figures that show …

News
1280px-epi-pen_1

Mylan’s promised half-price EpiPen not available until year’s end

October 5, 2016
Research and Development, Sales and Marketing Mylan, epipen

Consumers may have to wait until the end of the year for the half-price EpiPen, months after Mylan originally promised …

News
heather_bresch_2

Price-hiked EpiPen profits 66% higher than Mylan CEO claimed

September 27, 2016
Business Services, Manufacturing and Production, Sales and Marketing Heather Bresch, Mylan, epipen

In the latest development in the Mylan EpiPen scandal, it has been discovered that CEO Heather Bresch lied to US …

News
heather_bresch

EpiPen CEO appears before US lawmakers to defend “sickening” price hikes

September 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heather Bresch, Mylan, epipen

Disgraced Mylan CEO Heather Bresch (pictured) has appeared before US lawmakers to defend the company’s now infamous and much-maligned inflation …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024